BMI1 is a therapeutic target in recurrent medulloblastoma

David Bakhshinyan, Chitra Venugopal, Ashley A. Adile, Neha Garg, Branavan Manoranjan, Robin Hallett, Xin Wang, Sujeivan Mahendram, Parvez Vora, Thusyanth Vijayakumar, Minomi Subapanditha, Mohini Singh, Michelle Masayo Kameda-Smith, Maleeha Qazi, Nicole McFarlane, Aneet Mann, Olufemi A. Ajani, Blake Yarascavitch, Vijay Ramaswamy, Hamza FarooqSorana Morrissy, Liangxian Cao, Nadiya Sydorenko, Ramil Baiazitov, Wu Du, Josephine Sheedy, Marla Weetall, Young Choon Moon, Chang Sun Lee, Jacek M. Kwiecien, Kathleen H. Delaney, Brad Doble, Yoon Jae Cho, Siddhartha Mitra, David Kaplan, Michael D. Taylor, Thomas W. Davis, Sheila K. Singh

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'BMI1 is a therapeutic target in recurrent medulloblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences